About Viatris
Viatris is a global healthcare company committed to empowering people worldwide to live healthier at every stage of life. Formed in November 2020 through the combination of Mylan and Upjohn, Viatris brings together global pharmaceutical expertise, scientific capabilities, manufacturing strength and commercial experience.
The company focuses on expanding access to medicines, innovating to meet patient needs, and building trusted partnerships across the global healthcare community.
Viatris serves more than 165 markets and territories, and its medicines reach approximately 1 billion patients each year, with around 1,400 approved molecules across more than 10 major therapeutic areas. Through its broad portfolio and global capabilities, it continues to support healthcare systems and improve access to quality medicines around the world.